Alnylam's heart disease drug meets main goal in late-stage study-March 2024-www.financetom.com

Alnylam's heart disease drug meets main goal in late-stage study

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Alnylam's heart disease drug meets main goal in late-stage study

Jun 24, 2024 4:30 AM

June 24 (Reuters) - Alnylam Pharmaceuticals ( ALNY )

said on Monday that its drug vutrisiran met the main goal in a

late-stage study testing it as a treatment for a type of heart

disease.

Previous page： Stifel Financial to Buy Finance 500, CB Resource Next page： Oracle Adds New AI-Powered Services Within Product Offerings

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Stifel Financial to Buy Finance 500, CB Resource

Mar 14, 2024

09:17 AM EDT, 03/14/2024 (MT Newswires) -- Stifel Financial ( SF ) said Thursday it has agreed to buy Finance 500 and CB Resource, which operate as partners under common ownership and underwrite and issue certificates of deposits. Terms of the deal weren't provided. The acquisition is expected to provide Stifel with a scalable technology-driven platform, according to the company....

Oracle Adds New AI-Powered Services Within Product Offerings

Mar 14, 2024

09:18 AM EDT, 03/14/2024 (MT Newswires) -- Oracle (ORCL) said Thursday that it has added new generative artificial intelligence capabilities within its Oracle Fusion Cloud Applications Suite. The software giant said the additions include new generative AI capabilities embedded in existing business workflows and an expansion of the Oracle Guided Journeys' extensibility framework. Also on Thursday, Oracle said it has...

Italy's Eni lifts payout, bets on energy transition

Mar 14, 2024

MILAN (Reuters) -Italian energy group Eni said it would increase its distribution policy to between 30% and 35% of its cash flow from operations (CFFO) as it expects 8 billion euros ($8.7 billion)in net proceeds from asset portfolio management to 2027. The group will raise dividends on 2024 results by over 6% to 1 euro per share and buy back...

DraftKings Launches My Stat Sheet Tracking Tool

Mar 14, 2024

09:18 AM EDT, 03/14/2024 (MT Newswires) -- DraftKings ( DKNG ) said Thursday it has launched a gaming tool called My Stat Sheet that provides the ability to assess, track and interact with their personal stats through charts and information. The company said My Stat Sheet details time spent on the platform, deposits, withdrawals, contest involvement, wagers placed, and net...